| Conditions associated with severe carbon monoxide diffusion coefficient reduction. | |
| | |
MedLine Citation:
|
PMID: 21454061 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE: To identify conditions associated with severe carbon monoxide transfer coefficient reduction (Kco < 40% of predicted values). PATIENTS AND METHODS: We retrospectively reviewed pulmonary function tests, such as Kco measurement, in consecutive patients evaluated in the physiology unit of a University hospital over a 6-year period. Patients were included if they had at least 1 measure of severe Kco reduction, with further detailed pulmonary function tests, clinical data, and diagnostic procedures conducted within 6 months. RESULTS: 5576 patients underwent 9061 Kco measurements. 195 patients (3.5%) with Kco < 40% were investigated (156 males; mean age 62 ± 12 years). Mean Kco was 29 ± 9% of predicted values. The main conditions associated with severe Kco reduction were: emphysema (46%); interstitial lung disease (28%); combined pulmonary fibrosis and emphysema (16%); and pre-capillary pulmonary hypertension (8%). Systolic pulmonary artery pressure was ≥35 mmHg at echocardiography in 88% of patients. Right heart catheterization performed in 97 patients showed pre-capillary pulmonary hypertension in 86 of 195 patients (44%). Pulmonary hypertension was the most frequent condition associated with Kco severe reduction. Pulmonary hypertension was present in 29%, 53%, and 48% of patients with chronic obstructive pulmonary disease, interstitial lung disease, and combined pulmonary fibrosis and emphysema, respectively, and was disproportionate to the parenchymal lung disease (mean pulmonary artery pressure > 35 mmHg) in 63% of cases. CONCLUSION: Severe Kco reduction is frequently related to pulmonary hypertension, especially when associated with emphysema and/or interstitial lung disease. Systematic echocardiography is thus warranted in any patient with severe Kco diminution. |
| | |
Authors:
|
Lize Kiakouama; Vincent Cottin; Jean-Charles Glerant; Jean-Yves Bayle; Jean-François Mornex; Jean-François Cordier |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-29 |
Journal Detail:
|
Title: Respiratory medicine Volume: - ISSN: 1532-3064 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-4-1 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8908438 Medline TA: Respir Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011. Published by Elsevier Ltd. |
Affiliation:
|
Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Pneumologie - Centre de Référence des Maladies Rares Pulmonaires, France; Université de Lyon, Université Lyon I, UMR754 INRA-Vetagrosup EPHE, IFR128, Lyon, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Historical review of Haller's cells.
Next Document: Breathing retraining - A five-year follow-up of patients with dysfunctional breathing.